Knight Therapeutics Inc (TSX:GUD)
C$ 5.26 0.11 (2.14%) Market Cap: 530.22 Mil Enterprise Value: 416.12 Mil PE Ratio: 0 PB Ratio: 0.68 GF Score: 88/100

Knight Therapeutics Inc Annual Shareholders Meeting Transcript

May 11, 2022 / 01:00PM GMT
Release Date Price: C$5.22 (-1.69%)
Operator

Hello, you are joining Knight Therapeutics Annual General Meeting. I would now like to turn the call over to Jonathan Goodman, Chairman of the meeting. You may begin.

Jonathan Ross Goodman
Knight Therapeutics Inc. - Executive Chairman

Good morning, ladies and gentlemen. Welcome to Knight Therapeutics' Annual Meeting of Shareholders. Once again, this year, we have chosen to hold the meeting via live audio webcast. My name is Jonathan Goodman, Executive Chairman of Knight Therapeutics, and I will chair today's meeting.

Also with me on the call is Samira Sakhia, our President and CEO; and Bryan Kujawski, our External Counsel. Samira will act as secretary of today's meeting. Steve Gilbert and Claire Girard of Computershare Investor Services will be acting as scrutineers for this meeting.

Our agenda today is straightforward. First, we will conduct the formal part of our meeting. Following the formal part of the meeting, Samira will make a few remarks. Finally, we will do our best to answer any questions you may have. Questions, objections,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot